Verifying…
Home / Drug A–Z / Alben Tetracycline 250 mg Capsule_

Alben Tetracycline 250 mg Capsule_

NAFDAC Reg. No. B4-5290 · Drug

Registered with NAFDAC. Registration activeAs of 28 October 2026 · synced automatically from official sources.
Product
Alben Tetracycline 250 mg Capsule_
NAFDAC number
B4-5290
Active ingredient
Tetracycline Hydrochloride
Strength
250 mg
Form
Capsule
Pack size
10 x 10's (in PVC-Alu blisters)
Manufacturer
Not listed
Applicant (holder)
Alben Health Care Industries Ltd
Approved
30 Jul 2025
Status
Active View on NAFDAC ↗
Registration valid to
29 Jul 2030
WHO alerts
None found
Community reports
None
Times checked
0

What we found

  • Alben Tetracycline 250 mg Capsule_ is on the NAFDAC register with an active registration (B4-5290). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generated automatically from the NAFDAC register, WHO alerts and community data as of today. This is not medical advice. Always follow your doctor or pharmacist.

How to use Alben Tetracycline 250 mg Capsule_

What the official label says. If a doctor prescribed it, follow the prescription. Your pack's leaflet comes first if it is different.

Who it is for

To reduce the development of drug-resistant bacteria and maintain the effectiveness of tetracycline hydrochloride and other antibacterial drugs, tetracycline hydrochloride should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. …

How to take it and how often
  • Adults Usual daily dose, 1 gram as 500 mg twice a day or 250 mg four times a day
  • Higher doses such as 500 mg four times a day may be required for severe infections or for those infections which do not respond to the smaller doses
  • Pediatric patients above eight years of age Usual daily dose, 10 mg/lb to 20 mg/lb (25mg/kg to 50 mg/kg) body weight divided in four equal doses
  • Administration of adequate amounts of fluid with the capsule formulation of tetracycline is recommended to wash down the drug and reduce the risk of esophageal irritation and ulceration (see ADVERSE REACTIONS )
  • Absorption of tetracycline is impaired by antacids containing aluminum, calcium or magnesium and preparations containing iron, zinc or sodium bicarbonate
  • Food and some dairy products also interfere with absorption
  • When used in streptococcal infections, therapy should be continued for 10 days
  • For treatment of brucellosis, 500 mg tetracycline four times a day for three weeks accompanied by streptomycin, 1 gram intramuscularly twice daily the first week and once daily the second week
  • For the treatment of syphilis in patients allergic to penicillin, the following dosage of tetracycline is recommended: early syphilis (less than one year's duration), 500 mg four times a day for 15 days
  • Syphilis of more than one year's duration (except neurosyphilis), 500 mg four times a day for 30 days
  • For treatment of gonorrhea, the recommended dose is 500 mg by mouth four times a day for seven days. …
Children

See WARNINGS and DOSAGE AND ADMINISTRATION .

While you are taking it
  • Counsel patients that antibacterial drugs including tetracycline should only be used to treat bacterial infections
  • They do not treat viral infections (e.g., the common cold)
  • When tetracycline is prescribed to treat a bacterial infection, tell patients that although it is common to feel better early in the course of therapy, the medication should be taken exactly as directed
  • Skipping doses or not completing the full course of therapy may decrease the effectiveness of the immediate treatment and increase the likelihood that bacteria will develop resistance and will not be treatable by tetracycline or other antibacterial drugs in the future
Talk to a doctor first if

This drug is contraindicated in persons who have shown hypersensitivity to any of the tetracyclines.

Medicines it may not mix with

Since bacteriostatic drugs may interfere with the bactericidal action of penicillin, it is advisable to avoid giving tetracycline in conjunction with penicillin or other bactericidal antibacterials. Because the tetracyclines have been shown to depress plasma prothrombin activity, patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage. Absorption of tetracyclines is impaired by antacids containing aluminum, calcium or magnesium and preparations containing iron, zinc, or sodium bicarbonate. Concurrent use of tetracycline may render oral contraceptives less effective.

Warnings

Tooth Development The use of drugs of the tetracycline-class during tooth development (last half of pregnancy, infancy and childhood to the age of 8 years) may cause permanent discoloration of the teeth (yellow-gray-brown). This adverse reaction is more common during long-term use of the drugs but it has been observed following repeated short-term courses. Enamel hypoplasia has also been reported. Tetracycline drugs should not be used in this age group, except for anthrax, unless other drugs are not likely to be effective or are contraindicated. …

Possible side effects

Gastrointestinal: anorexia, nausea, epigastric distress, vomiting, diarrhea, glossitis, black hairy tongue, dysphagia, enterocolitis, and inflammatory lesions (with Candida overgrowth) in the anogenital region. Esophagitis and esophageal ulceration have been reported in patients receiving particularly the capsule and also the tablet forms of tetracyclines. Most of the patients were reported to have taken medication immediately before going to bed (see DOSAGE AND ADMINISTRATION ). Teeth : permanent discoloration of teeth may be caused during tooth development. Enamel hypoplasia has been reported (see WARNINGS ). Skin : fixed drug eruption, maculopapular and erythematous rashes. …

Pregnancy and breastfeeding

Pregnancy Teratogenic Effects Pregnancy Category D (see WARNINGS ) Nonteratogenic Effects (see WARNINGS ) Pregnant women with renal disease may be more prone to develop tetracycline-associated liver failure.

If you take too much

In case of overdosage, discontinue medication, treat symptomatically and institute supportive measures. Tetracycline is not dialyzable.

How to store it

Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature].

If you miss a dose

Take it when you remember, unless it is nearly time for the next dose. Then skip the missed one. Never take two doses at once to make up for it. Check your leaflet, as some medicines are different.

From the official U.S. FDA label for this active ingredient. Your pack may have a different strength, so always read its leaflet. If a doctor prescribed it, follow the prescription. Ask a pharmacist if you are unsure. Label dated 2026-05-22.

Label for tetracycline hydrochloride, the active ingredient registered with NAFDAC.

Check your pack of Alben Tetracycline 250 mg Capsule_

Add the expiry date on your pack for a full Trust Score.

3 free checks left today Official sources: NAFDAC · WHO · U.S. FDA · Health Canada · NLM

About Alben Tetracycline 250 mg Capsule_

What is in Alben Tetracycline 250 mg Capsule_?

Alben Tetracycline 250 mg Capsule_ contains Tetracycline Hydrochloride (250 mg), as capsule, according to its NAFDAC registration record.

Is Alben Tetracycline 250 mg Capsule_ registered with NAFDAC?

Yes. Alben Tetracycline 250 mg Capsule_ is listed on the NAFDAC register under registration number B4-5290, and its registration is active as of 28 October 2026.

Has Alben Tetracycline 250 mg Capsule_ been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches Alben Tetracycline 250 mg Capsule_ in our automatically synced alert list.

How can I check that my pack of Alben Tetracycline 250 mg Capsule_ is genuine?

Run a free authenticity scan with the NAFDAC number B4-5290, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

How do I take Alben Tetracycline 250 mg Capsule_?

Follow your prescription or the leaflet in your pack. The official label says: Adults Usual daily dose, 1 gram as 500 mg twice a day or 250 mg four times a day. Higher doses such as 500 mg four times a day may be required for severe infections or for those infections which do not respond to the smaller doses. For pediatric patients above eight years of age Usual daily dose, 10 mg/lb to 20 mg/lb (25mg/kg to 50 mg/kg) body weight divided in four equal doses…

What is Alben Tetracycline 250 mg Capsule_ used for?

To reduce the development of drug-resistant bacteria and maintain the effectiveness of tetracycline hydrochloride and other antibacterial drugs, tetracycline hydrochloride should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying a (Summarised from the official U.S. FDA label for tetracycline hydrochloride. Always follow your doctor or pharmacist.)

Patient reviews

–No reviews yet
5★
0
4★
0
3★
0
2★
0
1★
0
Have you used Alben Tetracycline 250 mg Capsule_? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from PillVera users, not medical advice. Report side effects to your doctor and to NAFDAC.